本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2010/9/101 分钟阅读
Schmid Laboratories, Inc. et al.; Withdrawal of Approval of Five New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of five new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →